Pharmacopuncture Therapy for Cervical Disc Herniation: A Pilot Study

Inclusion Criteria: 1. Symptoms of cervical disc herniation for less than 12 months 2. Numeric Rating Scale (NRS) of neck pain is more than 5 3. Symptoms of neuromuscular disease in one or both upper limbs (pain, pull, numbness, sensory abnormalities, motor abnormalities) 4. Discrimination findings above protusion, which can explain clinical symptoms on Cervical spine MRI or CT 5. 19-69 years old 6. participants who agreed and wrote informed consents Exclusion Criteria: 1. Case of being diagnosed with a specific serious disease that may cause neck pain(Migration of cancer reaching to spine, acute fracture of spine, spine dislocation) 2. Progressive neurologic deficits or severe neurologic deficits 3. Cause of pain due to soft tissue disease, not the spine(Cancer, fibromyalgia, RA, goat, or etc.) 4. Other chronic diseases(stroke, MI, kidney disease, diabetic neuropathy, dimentia, epilepsy, or etc.) that may interfere with the interpretation of therapeutic effects or outcomes 5. Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs that may affect outcomes 6. Inappropriate or unsafe pharmacopuncture therapy; hemorrhagic disease, taking anticoagulant drug, or severe diabetes patients who are likely to be infected 7. Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week 8. Pregnant, planning to get pregnant or lactating women 9. Participants who had undergone cervical surgery within 3 months 10. Participants who had participated in other clinical trial within 1 month, had participated in other study within 6 months from the date of selection, or have plan for participation in other trial during follow up period of this trial 11. Participants who can not write informed consent 12. Participants who is difficult to participate in the trial according to investigator's decision